Advertisement

Cancer Immunology, Immunotherapy

, Volume 33, Issue 6, pp 421–423 | Cite as

Effect of advanced aging on ability of mice to cause regression of an immunogenic lymphoma in response to immunotherapy based on depletion of suppressor T cells

  • Pamela L. Dunn
  • Robert J. North
Short communication

Summary

This study shows that two therapeutic agents, anti-CD4 mAb and vinblastine, capable of causing T-cellmediated regression of an established L5178Y lymphoma in 3-month-old mice, are incapable of causing regression of this tumor in 20- to 22-month-old mice. It is known that both agents are immunoaugmentative because of their ability to destroy tumor-induced CD4+ suppressor T cells preferentially. Therefore, the results indicate, that aged mice, unlike young mice, are not capable of generating therapeutic numbers of CD8+ effector T cells in the absence of suppressor cells.

Key words

Aging Immunotherapy T-cell mediated Lymphoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Awwad M, North RJ (1988) Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity. J Exp Med 168: 2193–2206Google Scholar
  2. 2.
    Dunn PL, North RJ (1991) Selective radiation resistance of immunologically induced T cells as the basis for irradiation-induced T-cellmediated regression of an immunogenic tumor. J Leukocyte Biol 49: 388–396Google Scholar
  3. 3.
    Flood PM, Urban JL, Kripke ML, Schrieber H (1981) Loss of tumorspecific and idiotype-specific immunity with age. J Exp Med 154: 275–290Google Scholar
  4. 4.
    Fitzgerald PA, Bennett M (1983) Aging of natural and acquired immunity of mice: II. Decreased T cell response to syngeneic tumor cells and parenteral-strain spleen cells. Cancer Invest 1: 139Google Scholar
  5. 5.
    Johnson TR, North RJ (1987) Frequency analysis of augmented CTL production associated withCorynebacterium parvum-induced tumor regression. Immunology 60: 361–366Google Scholar
  6. 6.
    Mackinodan T, Kay MMB (1980) Age influence on the immune system. Adv Immunol 29: 287–294Google Scholar
  7. 7.
    North RJ, Awwad M (1990) Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma. Immunology 71: 90–95Google Scholar
  8. 8.
    North RJ, Awwad M, Dunn PL (1989) The immune response to tumors. Transplant Proc 21: 575–577Google Scholar
  9. 9.
    Smith GS, Walford RL, Mickey MR (1973) Life span and incidence of cancer and other diseases in selected long-lived mice and their F1 hybrids. J Natl Cancer Inst 50: 1195–1213Google Scholar
  10. 10.
    Thoman ML, Weigle WO (1989) The cellular and subcellular basis of immunosenescence. Adv Immunol 46: 221–261Google Scholar
  11. 11.
    Urban JL, Schrieber H (1984) Rescue of tumor-specific immune response of aged mice in vitro. J Immunol 133: 527–534Google Scholar
  12. 12.
    Wade AW, Szewczuk MR (1984) Aging, idiotype repertoire shifts, and compartmentalization of the mucosal-associated lymphoid system. Adv Immunol 36: 143Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • Pamela L. Dunn
    • 1
  • Robert J. North
    • 1
  1. 1.The Trudeau InstituteSaranac LakeUSA

Personalised recommendations